ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript
ADC Therapeutics SA reports earnings inline with expectations. Reported EPS is $-0.56 EPS, expectations were $-0.56.
Adc Therapeutics Sa (ADCT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 15,269,217 | $68,558,784 | -1% | 2.51% |
| 2. | Prosight Capital Lawrence Hawkins | 7,050,300 | $31,655,847 | +9% | 8.8% |
| 3. | Millennium Management Israel Englander | 1,010,437 | $4,536,862 | -63% | 0% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 1,000,000 | $4,490,000 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 952,464 | $4,276,563 | -49% | 0% |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.89 | 6,995 | Director | 53,005 | 2024-06-17 | Filing | |
| $2.89 | 6,995 | Director | 79,502 | 2024-06-17 | Filing | |
| $2.89 | 1,193 | Director | 182,644 | 2024-06-17 | Filing | |
| $2.89 | 1,437 | Director | 106,627 | 2024-06-17 | Filing | |
| $2.89 | 1,437 | Director | 213,900 | 2024-06-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,525,741 | $2,532,730 | 0% | |
| 2. | 1,459,514 | $2,422,793 | 0% | |
| 3. | 1,013,540 | $1,682,476 | 0.3% | |
| 4. | 850,737 | $1,412,224 | 0.94% | |
| 5. | 781,937 | $1,298,016 | 0% |
News See All
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
ADC Therapeutics SA misses on earnings expectations. Reported EPS is $-1.03 EPS, expectations were $-0.47.
5 Top Performing European Stocks So Far in 2024
In this piece, we will take a look at the five top performing European stocks so far in 2024.
ADC Therapeutics SA (NYSE:ADCT) Q3 2023 Earnings Call Transcript
Operator: Welcome to the ADC Therapeutics Third Quarter 2023 Financial Results Conference Call. My name is Cathy and I will be your operator for today's call.
ADC Therapeutics SA (NYSE:ADCT) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to the ADC Therapeutics Second Quarter 2023 Financial Results Conference Call. My name is Corey, and I'll be your operator for today's call.
ADC Therapeutics SA (NYSE:ADCT) Q4 2022 Earnings Call Transcript
Operator: Welcome to the ADC Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Andrew, and I'll be your operator for today's call.
ADC Therapeutics SA (NYSE:ADCT) Q3 2022 Earnings Call Transcript
Operator: Welcome to the ADC Therapeutics Third Quarter 2022 Financial Results Conference Call. My name is Kevin, and I'll be your operator for today's call.
5 Best Stocks to Buy Under $20 According to Jeremy Green's Redmile Group
In this piece, we will take a look at the top five best stocks to buy under $20 according to Jeremy Green's Redmile Group.
Top 5 Biotech Stocks to Buy According to Jeremy Green's Redmile Group
In this article, we discuss the top 5 biotech stocks to buy according to Jeremy Green's Redmile Group.
Is ADCT A Good Stock To Buy Now?
In this article we will take a look at whether hedge funds think ADC Therapeutics SA (NYSE:ADCT) is a good investment right now.
Billionaire Hedge Funds
